RANOLAZINE

Product NDC
71610-971
11-digit product format
716100971
Labeler code
71610
Product ID
71610-971_45236b92-015e-16d3-e063-6394a90a1068
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
RANOLAZINE
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
ANDA211829
Marketing category
ANDA
Marketing start
2025-06-30
Substance
RANOLAZINE
Active strength
500 mg/1
Pharmacologic classes
Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A211829-001RANOLAZINERANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-04
A211829-002RANOLAZINERANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A211829-001AB
A211829-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-04caaa826d4ba7…
2026-08-18 06:07:402026-07A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-04caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-04011fe1cb6892…
2026-02-19 14:30 UTC2026-02A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-04011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-0431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-0431067a03dcf5…
2025-08-23 18:47 UTC2025-08A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-046a471c1ec25d…
2025-08-23 18:47 UTC2025-08A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-046a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-04fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-04fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-04b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-04b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-0403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-0403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-042680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-042680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-045bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-045bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-04d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-04d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-04d06236e962d9…
2024-10-29 15:01 UTC2024-10A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-04d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-0479d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-0479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-04301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-04301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-041e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-041e350fbaab3a…
2024-05-31 18:47 UTC2024-05A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-048072bd15b7f6…
2024-05-31 18:47 UTC2024-05A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-048072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-045c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-045c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-045d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-045d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-044b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-044b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-0474a2ff9319b5…
2019-12-13 00:20 UTC2019-12A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-0474a2ff9319b5…
2022-03-09 01:35 UTC2022-03A211829-001RANOLAZINE500MGTABLET, EXTENDED RELEASE / ORALAB2019-06-04bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A211829-002RANOLAZINE1GMTABLET, EXTENDED RELEASE / ORALAB2019-06-04bb7c543d1eb4…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A211829-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A211829-002AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A211829-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A211829-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A211829-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A211829-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A211829-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A211829-002AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A211829-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A211829-002AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A211829-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A211829-002AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A211829-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A211829-002AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A211829-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A211829-002AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A211829-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A211829-002AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A211829-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A211829-002AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A211829-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A211829-002AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A211829-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A211829-002AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A211829-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A211829-002AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A211829-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A211829-002AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A211829-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05A211829-002AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A211829-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A211829-002AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A211829-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A211829-002AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A211829-001AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A211829-002AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A211829-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A211829-002AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A211829-001AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A211829-002AB1bb7c543d1eb4…

Additional Listing Data#

Finished product
Yes
Brand name base
RANOLAZINE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
RANOLAZINE500 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
A6IEZ5M406Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
616749Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
45236b7d-3728-1e13-e063-6394a90ad77fAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4367aed1-e488-b72c-d0ec-178a4e054129Product name920250624
ddc83a74-720a-4975-8550-c4bd979c9094Product name120221212

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71610-971-42RANOLAZINE1800 in 1 BOTTLETABLET, FILM COATED, EXTENDED RE18001

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
71610-971-42EA - Each71610-9713ded5bfb-9b49-4b4c-92be-c7fdd2a3966112026-03-17

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RANOLAZINERANOLAZINERadha Pharmaceuticals, Inc38d2833d-44b8-8d46-e063-6394a90a74d82026-02-20Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211829
application number: ANDA211829
RANOLAZINERANOLAZINEAphena Pharma Solutions - Tennessee, LLC45236b7d-3728-1e13-e063-6394a90ad77f2025-12-04Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211829
application number: ANDA211829
ndc (product): 71610-971
RANOLAZINERANOLAZINEScieGen Pharmaceuticals, Inc71d50258-75b7-4801-b0f4-c34fe883d57d2024-12-24Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211829
application number: ANDA211829
RanolazineRANOLAZINEProficient Rx LPc7ed8234-e6bd-4f19-a1ce-40f272a790362024-07-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211829
application number: ANDA211829
RanolazineRANOLAZINEProficient Rx LP989e1688-a0b5-4297-bf91-234de2a0b4452022-03-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211829
application number: ANDA211829
RanolazineRANOLAZINEWestminster Pharmaceuticals, LLCb91e88a0-04d0-4d0d-92d8-966b27a48e292021-09-02Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211829
application number: ANDA211829

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
616749ranolazine 500 MG 12HR Extended Release Oral TabletPSN45236b7d-3728-1e13-e063-6394a90ad77f1
61674912 HR ranolazine 500 MG Extended Release Oral TabletSCD45236b7d-3728-1e13-e063-6394a90ad77f1
616749ranolazine 500 MG 12 HR Extended Release Oral TabletSY45236b7d-3728-1e13-e063-6394a90ad77f1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
71610-971-42716100971421800 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-971-42) 2025-12-03NoNoCurrent